This Viewpoint advocates for more careful consideration of families and children in policymaking surrounding naloxone coprescribing or accessibility. Share: Previous Post Effects on Body Mass Index After the Philadelphia Beverage Tax Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Error in Title Clinical Practice Guidelines Age- and Sex-Specific Differences in the Presentation of Avoidant Restrictive Food Intake Disorder in Youths Clinical Practice Guidelines JAMA Pediatrics Clinical Practice Guidelines Disaggregating Racial and Ethnic Data to Examine Intersectional Identities, Bias-Based Bullying, and Mental Health Clinical Practice Guidelines Error in Introduction Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.